Series A · Healthtech · Helsinki, Finland · Founded 2021 · 20–50 employees
CurifyLabs revolutionizes pharmaceutical compounding with automated 3D printing technology that enables pharmacies to manufacture personalized medicines quickly and accurately. Their Pharma Kit solution makes the process four times faster than manual compounding while providing limitless dosing flexibility and better patient safety. Founded in 2021 based on 13 years of academic research, the company has raised €17.6 million total funding with recent €6.7M round led by Springvest. They operate across Finland, US, and Germany serving pharmacies with validated, quality-controlled automated compounding solutions.